News

COVID-19: WHO, partners roll out faster tests for poorer nations

COVID-19 WHO

The World Health Organization and its leading partners have agreed to roll out 120 million rapid-diagnostic tests for the coronavirus to help lower- and middle-income countries make up ground in a testing gap with richer countries – even if it’s not fully funded yet.

At USD 5 a piece, the antigen-based rapid diagnostic tests for which WHO issued an emergency-use listing last week, the program initially requires USD 600 million and is to get started as early as next month to provide better access to areas where it’s harder to reach with PCR tests that are used often in many wealthier nations, the WHO announced on Monday.

WHO Director-General Tedros Adhanom Ghebreyesus hailed the program as “good news” in the fight against COVID-19.

“These tests provide reliable results in approximately 15 to 30 minutes, rather than hours or days, at a lower price with less sophisticated equipment,” he was quoted saying by a PTI report.

“This will enable the expansion of testing, particularly in hard-to-reach areas that do not have lab facilities or enough trained health workers to carry out PCR tests.”

Also read: Keep your heart healthy during COVID-19 with palliative care

“We have an agreement, we have seed funding and now we need the full amount of funds to buy these tests,” he said, without specifying.

Dr. Catharina Boehme, chief executive of a non-profit group called the Foundation for Innovative New Diagnostics, said the rollout would be in 20 countries in Africa, and would rely on support of groups including the Clinton Health Access Initiative. She said the diagnostic tests will be provided by SD Biosensor and Abbott. Peter Sands, the executive director of the Global Fund, a partnership that works to end epidemics, said it would make an initial USD 50 million available from its COVID-19 response mechanism.

He said the deployment of the quality antigen rapid diagnostic tests will be a “significant step” to help contain and combat the coronavirus. “They’re not a silver bullet, but hugely valuable as a complement to PCR tests, since although they are less accurate, they’re much faster, cheaper and don’t require a lab,” he said.

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Most Popular

X
Subscribe Newsletter
To Top